Johnson & Johnson has announced that it will stop selling four models of transvaginal surgical mesh implants following numerous lawsuits by women who allege that they were injured by these products. More than 1,000 transvaginal mesh lawsuits have already been filed against Ethicon, a division of Johnson & Johnson that makes surgical mesh products for transvaginal repair surgery.
In a letter to the Food and Drug Administration, Johnson & Johnson stated that it plans to halt sales of the four surgical mesh products within 120 days. The implants being pulled from the market include the Gynecare Prolift Pelvic Floor Repair System, Gynecare TVT Secur System and Gynecare Prosima Pelvic Floor Repair System.
Surgical mesh lawsuits against Johnson & Johnson and its subsidiaries have alleged that the products are more likely to cause problems after implantation than traditional surgical repair. The FDA received more than 1,500 reports of problems with transvaginal mesh implants between 2008 and 2010, including vaginal mesh erosion, infection and bleeding.
Johnson & Johnson also sent notification of its decision to halt sales of the implants to judges that are overseeing surgical mesh lawsuits in New Jersey and West Virginia. Lawyers involved in the transvaginal mesh litigation have stated that the decision to halt sales of the implants may be an attempt by Johnson & Johnson to stop additional lawsuits from being filed by patients who used these products.